Value of Thyroid Transcription Factor-1, E-Cadherin, BG8, WT1, and CD44S Immunostaining in Distinguishing Epithelial Pleural Mesothelioma From Pulmonary and Nonpulmonary Adenocarcinoma
- 1 April 2000
- journal article
- research article
- Published by Wolters Kluwer Health in The American Journal of Surgical Pathology
- Vol. 24 (4) , 598-606
- https://doi.org/10.1097/00000478-200004000-00016
Abstract
The distinction between malignant pleural mesotheliomas and adenocarcinomas, particularly those originating in the lung, is a difficult diagnostic problem that can be facilitated by the use of immunohistochemical markers. In this study, the immunoreactivity of thyroid transcription factor-1 (TTF-1), E-cadherin, BG8, WT1, and CD44S was investigated in 50 epithelial mesotheliomas, and 40 pulmonary and 95 nonpulmonary adenocarcinomas. After analyzing the results, it was concluded that E-cadherin and BG8 are useful markers for distinguishing between epithelial mesotheliomas and adenocarcinomas of various origins, including the lung. Because TTF-1 expression is found almost exclusively in adenocarcinomas of the lung but is absent in mesotheliomas, immunostaining for this marker is particularly useful for distinguishing between these two malignancies. Although WT1 immunostaining may also be useful, its value, as determined in this study, is lower than that reported by other investigators. CD44S immunostaining does not have any practical value in discriminating between epithelial mesothelioma and lung adenocarcinoma.Keywords
This publication has 44 references indexed in Scilit:
- TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lungCancer Letters, 1998
- Differential Expression of CD44S and Hyaluronic Acid in Malignant Mesotheliomas, Adenocarcinomas, and Reactive Mesothelial HyperplasiasApplied Immunohistochemistry & Molecular Morphology, 1998
- Anti‐cytokeratin 5/6: a positive marker for epithelioid mesotheliomaHistopathology, 1997
- CD44H expression in reactive mesothelium, pleural mesothelioma and pulmonary adenocarcinomaHistopathology, 1997
- Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma.Journal of Clinical Pathology, 1997
- Calretinin: A Novel Immunocytochemical Marker for MesotheliomaThe American Journal of Surgical Pathology, 1996
- Mesothelioma‐binding antibodies: thrombomodulin, OV 632 and HBME‐1 and their use in the diagnosis of malignant mesotheliomaHistopathology, 1996
- OV 632 and MOC 31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin fixed and paraffin wax embedded material.Journal of Clinical Pathology, 1995
- The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis.Molecular and Cellular Biology, 1994
- Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinomaHuman Pathology, 1993